Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 2 1

Status

Completed 3Terminated 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1

Conditions

Sarcoma, Alveolar Soft Part 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain 1Agnosia 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Diazepam × Clear all
NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
34 enrolled 22 charts
Sarcoma

Sarcoma, Alveolar Soft Part

NCT02935972 2017-01-23

Combined Intravenous Diazepam, Local Periprostatic Nerve Block for Prostate Biopsy

Assiut University

Phase 2/3 Completed
336 enrolled
Genitourinary

Agnosia, Pain, Prostatic Neoplasms

NCT01759706 2014-12-05

Safety and Feasibility Study of Enhanced Recovery in Pancreaticoduodenectomy

Università Vita-Salute San Raffaele

Phase NA Completed
123 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡